Latest news
Intellia Therapeutics Announces Second Quarter 2026 Financial Results and Business Updates - Intellia TherapeuticsIntellia Therapeutics · Thu, 06 Aug 2026 11:05:12 GMTCRISPR Therapeutics Launches Clinical Trials of In Vivo Gene Editors for Hypertension, AATD - precisionmedicineonline.comprecisionmedicineonline.com · Tue, 04 Aug 2026 14:29:21 GMT